XML 23 R12.htm IDEA: XBRL DOCUMENT v3.21.2

Balance Sheet Details

6 Months Ended

Jun. 30, 2021

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Balance Sheet Details

5. Balance Sheet Details

Inventory consisted of the following (in thousands):

		June 30, 2021				December 31, 2020
Finished goods		$	2,094			$	1,453
Work in process			7,188				6,367
Raw material			1,504				1,862
		$	10,786			$	9,682

Accrued liabilities consisted of the following (in thousands):

		June 30, 2021				December 31, 2020
Accrued compensation and benefits		$	21,291			$	25,811
Accrued research and development services			20,940				28,380
Accrued consulting and professional fees			15,952				18,969
Accrued sales allowances			12,512				14,115
Current portion of lease liabilities			7,521				5,087
Current portion of accrued branded prescription drug fees			5,203				1,845
Other			2,844				3,267
		$	86,263			$	97,474

X

- References

No definition available.

+ Details

Name:	us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-URI http://asc.fasb.org/topic&trid=2122208

+ Details

Name:	us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration